Join
Live feed
·
PRReleasevia Quantisnow
MediWound Ltd. logo

Independent DSMB Recommends MediWound’s EscharEx® Phase III VALUE Study Continue Without Modification

ByQuantisnow·Wall Street's wire, on your screen.
MDWD· MediWound Ltd.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MDWD (MediWound Ltd.) and more on Quantisnow.